金河生物(002688.SZ):子公司杭州佑本獲得《獸藥生產許可證》和《獸藥GMP證書》
格隆匯5月25日丨金河生物(002688.SZ)公佈,近期,公司二級子公司杭州佑本動物疫苗有限公司(簡稱“杭州佑本”)收到浙江省農業農村廳核發的《獸藥生產許可證》和《獸藥GMP證書》。
杭州佑本該次依據《獸藥管理條例》和《獸藥生產質量管理規範(2020年修訂)》通過認證的項目為細胞培養病毒滅活疫苗(含懸浮培養工藝)、細胞懸浮培養病毒滅活疫苗、細胞培養病毒活疫苗(2條)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.